Surrozen, Inc.

Healthcare

NASDAQ:SRZN · NASDAQ Capital Market

Market Cap $170.11M Beta 0.51 P/E (TTM) -0.7

$23.25 -4.74%

-$1.14 today

52W Low $8.00High $35.00

Vol 0.20M · Avg 0.11M

EPS (TTM) -$31.29Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+132.73%

Period High

$34.13

Period Low

$8.29

Latest

$23.25

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Immix Biopharma, Inc.

NASDAQ:IMMX

$506.48M

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

$343.91M

Opus Genetics, Inc.

NASDAQ:IRD

$335.63M

Agenus Inc.

NASDAQ:AGEN

$123.47M

Cognition Therapeutics, Inc.

NASDAQ:CGTX

$104.85M

Seer, Inc.

NASDAQ:SEER

$94.57M

Instil Bio, Inc.

NASDAQ:TIL

$51.20M

Tevogen Bio Holdings Inc.

TVGN

$43.63M

VistaGen Therapeutics, Inc.

VTGN

$22.67M

Atossa Therapeutics, Inc.

ATOS

$17.22M

What is the latest SRZN filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does SRZN have?

Intrinsic Alpha currently shows 20 recent filings for SRZN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.